Efficacy and Safety of Valganciclovir in Congenital Cytomegalovirus Infection with Isolated Intrahepatic Cholestasis: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Valganciclovir in Congenital Cytomegalovirus Infection with Isolated Intrahepatic Cholestasis: A Randomized Controlled Trial

Published:2024 Issue:5 Volume:27 Page:298
ISSN:2234-8646
Container-title:Pediatric Gastroenterology, Hepatology & Nutrition
language:en
Short-container-title:Pediatr Gastroenterol Hepatol Nutr

Author:

Mahmud Salahuddin¹^ORCID,Farhana Tanzila¹^ORCID,Anik Ataul Mustufa²^ORCID,Ahmed Fayaza³^ORCID,Parvez Mashud⁴^ORCID,Baidya Madhabi¹^ORCID,Rashid Rafia⁵^ORCID,Tasneem Farhana⁶^ORCID,Hasan Ahmed Rashidul¹^ORCID,Alam Mohammad Jahangir⁷,Muaz Shafi Ahmed¹^ORCID

Affiliation:

1. Department of Pediatric Gastroenterology, Hepatology & Nutrition, Bangladesh Shishu Hospital & Institute, Dhaka, Bangladesh.

2. Department of Statistics, Shahjalal University of Science and Technology, Sylhet, Bangladesh.

3. Child Development Centre, HSM, DGHS, Dhaka, Bangladesh.

4. Department of Pathology, Bangladesh Shishu Hospital & Institute, Dhaka, Bangladesh.

5. Department of Pediatric Gastroenterology, Dr. M R Khan Shishu Hospital & Institute of Child Health, Dhaka, Bangladesh.

6. Department of Pediatrics, BIHS General Hospital, Diabetic Association of Bangladesh, Dhaka, Bangladesh.

7. Department of Pediatrics, Bangladesh Shishu Hospital & Institute, Dhaka, Bangladesh.

Funder

Planning, Monitoring, and Research

Operational Plan, Directorate General of Health Services

Publisher

XMLink

Link

https://pghn.org/pdf/10.5223/pghn.2024.27.5.298

Reference56 articles.

1. Perinatal cytomegalovirus hepatitis in Saudi infants: A case series

2. Predictor of Liver Biochemistry Improvement in Patients with Cytomegalovirus Cholestasis after Ganciclovir Treatment

3. Efficacy and Tolerability of Valganciclovir 6 Months vs 6 Weeks in Symptomatic Cytomegalovirus Infection in Infants: An Open Level Randomized Controlled Trial